These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 6119640)

  • 1. Is propranolol antischizophrenic?
    Peet M
    Neuropharmacology; 1981 Dec; 20(12B):1303-7. PubMed ID: 6119640
    [No Abstract]   [Full Text] [Related]  

  • 2. [Difficulties of evaluation of the results of drug treatment of schizophrenia].
    Welbel L
    Psychiatr Pol; 1980; 14(1):51-7. PubMed ID: 6102774
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of certain cardiological drugs in the treatment of schizophrenia: review of the literature].
    Llorca PM; Wolf MA
    J Psychiatry Neurosci; 1991 Mar; 16(1):19-24. PubMed ID: 1675588
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose selection and comparator drugs in schizophrenia research.
    Kane JM
    J Clin Psychiatry; 2001; 62 Suppl 9():29-32; discussion 33-4. PubMed ID: 11379828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quetiapine for schizophrenia.
    Med Lett Drugs Ther; 1997 Dec; 39(1016):117-8. PubMed ID: 9422044
    [No Abstract]   [Full Text] [Related]  

  • 6. Schizophrenia: recent advances in psychopharmacology.
    Sharma T
    Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):194-8. PubMed ID: 8777500
    [No Abstract]   [Full Text] [Related]  

  • 7. Propranolol, anxiety, and tardive dyskinesia.
    Bacher NA; Lewis HA
    J Clin Psychiatry; 1983 May; 44(5):196. PubMed ID: 6133849
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of propranolol on the central nervous system: its antischizophrenic action].
    Poli A; Palermo-Neto J
    Rev Paul Med; 1984; 102(5):215-8. PubMed ID: 6397826
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopaminergic deficit and the role of amisulpride in the treatment of schizophrenia.
    Kasper S
    Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S19-26. PubMed ID: 12685918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Resistant schizophrenia: what chemotherapy?].
    Vanelle JM
    Ann Med Psychol (Paris); 1993 Apr; 151(4):346-51. PubMed ID: 7904434
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug treatment of schizophrenia.
    Hollister LE
    Psychiatr Clin North Am; 1984 Sep; 7(3):435-52. PubMed ID: 6148741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of beta-adrenergic blocking agents in anxiety disorders and schizophrenia.
    Hayes PE; Schulz SC
    Pharmacotherapy; 1983; 3(2 Pt 1):101-17. PubMed ID: 6134273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol in the treatment of tardive dyskinesia.
    Perényi A; Farkas A
    Biol Psychiatry; 1983 Mar; 18(3):391-4. PubMed ID: 6132627
    [No Abstract]   [Full Text] [Related]  

  • 15. Prediction of the outcome of a phase 3 clinical trial of an antischizophrenic agent (quetiapine fumarate) by simulation with a population pharmacokinetic and pharmacodynamic model.
    Kimko HC; Reele SS; Holford NH; Peck CC
    Clin Pharmacol Ther; 2000 Nov; 68(5):568-77. PubMed ID: 11103759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderators of placebo response to antipsychotic treatment in patients with schizophrenia: a meta-regression.
    Welge JA; Keck PE
    Psychopharmacology (Berl); 2003 Feb; 166(1):1-10. PubMed ID: 12494247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic treatment of adolescent and child schizophrenia.
    Young CM; Findling RL
    Expert Rev Neurother; 2004 Jan; 4(1):53-60. PubMed ID: 15853615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schizophrenia drug says goodbye to dopamine.
    Weinberger DR
    Nat Med; 2007 Sep; 13(9):1018-9. PubMed ID: 17828217
    [No Abstract]   [Full Text] [Related]  

  • 19. Partial response to antipsychotic treatment: the patient with enduring symptoms.
    Emsley RA
    J Clin Psychiatry; 1999; 60 Suppl 23():10-3. PubMed ID: 10625194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sertindole, a new atypical antipsychotic for the treatment of schizophrenia.
    Brown LA; Levin GM
    Pharmacotherapy; 1998; 18(1):69-83. PubMed ID: 9469684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.